By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Anavex Life Sciences Corp. 

51 West 52nd Street
7th floor
New York  New York  10019  U.S.A.
Phone: 1-844-689-3939 Fax: n/a


Company News
Anavex (AVXL) Presents Positive Initial Phase IIa Study Data With ANAVEX 2-73 Showing Early Evidence Of Improving Cognition In Patients With Alzheimer’s Disease At AAIC 2015 7/22/2015 7:10:09 AM
Anavex (AVXL) To Present Initial Clinical Data From The Phase IIa Clinical Trial Of ANAVEX 2-73 At The Alzheimer’s Association International Conference (AAIC) 6/30/2015 7:17:33 AM
Anavex (AVXL) Strengthens Board Of Directors 6/18/2015 10:57:31 AM
Anavex (AVXL) Encouraged By Data Showing Sigma-1 Receptor Reduces Tau Dysfunction, A Hallmark Of Alzheimer's Disease 5/21/2015 8:58:15 AM
Anavex (AVXL) Releases Promising Full Preclinical Epilepsy Data At Antiepileptic Drug Trials XIII Conference 5/18/2015 10:05:58 AM
Anavex (AVXL) Reports Fiscal Second Quarter 2015 Financial Results 5/15/2015 10:25:47 AM
Anavex (AVXL) To Present At 2015 Marcum Conference On May 27th 5/13/2015 12:53:00 PM
Anavex (AVXL) To Present On Sigma-1 Receptors At The World Orphan Drug Congress And To Reveal New Epilepsy Data At Antiepileptic Drug Trials XIII Conference 4/23/2015 10:08:58 AM
Anavex (AVXL) Encouraged By New Scientific Data Revealing Positive Role Of Sigma-1 Receptors In Brain Injuries 4/7/2015 7:16:39 AM
Anavex (AVXL) Presents Positive Results For Both ANAVEX 2-73 And ANAVEX 3-71 In Alzheimer's Models At 2015 AD/PD Conference 3/23/2015 7:46:46 AM